We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.83%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$823M
AUM Growth
+$71.1M
(+9.5%)
Cap. Flow
+$54.2M
Cap. Flow
% of AUM
6.59%
Top 10 Holdings %
Top 10 Hldgs %
50.09%
Holding
190
New
61
Increased
39
Reduced
31
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$19.1M |
| 2 |
Macerich
MAC
|
+$12.1M |
| 3 |
EVA
Enviva Inc.
EVA
|
+$9.8M |
| 4 |
Okta
OKTA
|
+$8.15M |
| 5 |
PEGI
Pattern Energy Group Inc. Class A
PEGI
|
+$7.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rithm Capital
RITM
|
+$19.4M |
| 2 |
Zimmer Biomet
ZBH
|
+$12.9M |
| 3 |
Oracle
ORCL
|
+$12.8M |
| 4 |
United Rentals
URI
|
+$10.4M |
| 5 |
CIO
City Office REIT
CIO
|
+$10.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.81% |
| 2 | Technology | 10.73% |
| 3 | Utilities | 6.45% |
| 4 | Materials | 4.95% |
| 5 | Energy | 4.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Vertex Pharmaceuticals
VRTX
$124B
| $375K | 0.05% |
2,500
-16,000
| -86% | -$2.37M |
|
|
WBA
102
DELISTED
Walgreens Boots Alliance
WBA
| $363K | 0.04% |
+5,000
| New | +$352K |
|
|
ADVM
103
DELISTED
Adverum Biotechnologies
ADVM
| $350K | 0.04% |
+10,000
| New | +$329K |
|
104
8x8 Inc
EGHT
$269M
| $338K | 0.04% |
24,000
-6,000
| -20% | -$82.9K |
|
105
Regenxbio
RGNX
$617M
| $334K | 0.04% |
10,000
| – | – |
|
|
NBIS
106
Nebius Group N.V.
NBIS
$38.6B
| $328K | 0.04% |
10,000
-20,000
| -67% | -$653K |
|
|
PTE
107
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $327K | 0.04% |
+564
| New | +$359K |
|
108
AtriCure
ATRC
$2.02B
| $319K | 0.04% |
17,500
+2,500
| +17% | +$49.5K |
|
109
Atlassian
TEAM
$26.4B
| $319K | 0.04% |
7,000
-12,000
| -63% | -$558K |
|
110
Aldeyra Therapeutics
ALDX
$95.9M
| $306K | 0.04% |
45,000
+5,448
| +14% | +$35.9K |
|
|
CY
111
DELISTED
Cypress Semiconductor
CY
| $305K | 0.04% |
+20,000
| New | +$318K |
|
|
FNSR
112
DELISTED
Finisar Corp
FNSR
| $305K | 0.04% |
15,000
-202,500
| -93% | -$4.21M |
|
|
GRDX
113
GridAI Technologies Corp
GRDX
$19.6M
| $300K | 0.04% |
+1
| New | +$397K |
|
114
CALL
Sunrun
RUN
$2.26B
| $295K | 0.04% |
+50,000
| New | +$287K |
|
115
NVIDIA
NVDA
$4.67T
| $290K | 0.04% |
60,000
-100,000
| -63% | -$497K |
|
|
ALBO
116
DELISTED
Albireo Pharma Inc
ALBO
| $289K | 0.04% |
+11,300
| New | +$287K |
|
|
DERM
117
DELISTED
Dermira, Inc.
DERM
| $278K | 0.03% |
10,000
| – | – |
|
118
Cerus
CERS
$577M
| $270K | 0.03% |
80,000
| – | – |
|
119
Option Care Health
OPCH
$3.79B
| $262K | 0.03% |
22,500
+3,750
| +20% | +$37.9K |
|
|
AKCA
120
DELISTED
Akcea Therapeutics Inc
AKCA
| $260K | 0.03% |
15,000
+5,000
| +50% | +$98K |
|
121
Ambarella
AMBA
$2.98B
| $235K | 0.03% |
+4,000
| New | +$222K |
|
122
Rapid7
RPD
$628M
| $224K | 0.03% |
+12,000
| New | +$222K |
|
|
ACER
123
DELISTED
Acer Therapeutics Inc
ACER
| $212K | 0.03% |
+15,300
| New | +$249K |
|
|
ACGN
124
DELISTED
Aceragen Inc
ACGN
| $211K | 0.03% |
+736
| New | +$210K |
|
125
Gyre Therapeutics
GYRE
$639M
| $205K | 0.02% |
+2,000
| New | +$102K |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
PHS
Ardsley Advisory Partners's Q4 2017 Portfolio in Review
As of Q4 2017, Ardsley Advisory Partners held 190 positions worth $823M, up 9.5% from $752M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Ardsley Advisory Partners deployed $54.2M of net new capital in Q4 2017, opening 61 new positions and adding to 39 existing holdings. Its largest new stake was Macerich: 198,500 shares worth $13M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Technology and Utilities.
On the sell side, the largest reduction was PARSLEY ENERGY INC, an estimated $9.35M trimmed.
- Ardsley Advisory Partners's largest Q4 2017 buy was Macerich: 198,500 shares worth $13M.
- Ardsley Advisory Partners added most to AbbVie in Q4 2017, an estimated $19.1M increase.
- Ardsley Advisory Partners's biggest Q4 2017 reduction was PARSLEY ENERGY INC, cutting an estimated $9.35M.
- Ardsley Advisory Partners fully exited Rithm Capital in Q4 2017, selling an estimated $19.4M.
- Ardsley Advisory Partners's ten largest holdings make up 50% of its $823M portfolio in Q4 2017.
- Ardsley Advisory Partners opened 61 new positions and closed 53 in Q4 2017.
- Ardsley Advisory Partners's portfolio value rose 9.5% quarter-over-quarter to $823M.
Based on Ardsley Advisory Partners's 13F filing for Q4 2017, filed 14 Feb 2018.